Acetal

Quick links to important sections

Acetal

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acetal

Property Description
Active Ingredients Aspirin, Paracetamol
Form Tablet (Fixed-Dose Combination)
Pharmacological Class Analgesic and Antipyretic
Common Use Symptomatic pain and fever relief
Origin Synthetic compound

Acetal is a fixed-dose combination (FDC) medicine classified as an analgesic and antipyretic agent, specifically formulated to provide comprehensive symptomatic relief from pain and fever. This synthetic compound is typically presented in a standard oral tablet dosage form, combining two distinct active ingredients to enhance its therapeutic action.


What Type of Medicine Is Acetal?

Acetal is a combination drug that simultaneously delivers two separate active agents, reflecting a dual-pronged approach to symptom management. This FDC architecture is utilized when combining agents provides a greater therapeutic benefit than using either medicine alone. The overall classification of Acetal is as a non-opioid analgesic and antipyretic combination, a pairing that is clinically recognized for its efficacy in treating common, acute pain syndromes. The combination of aspirin and acetaminophen (paracetamol) is more efficacious for acute pain relief than either agent used in isolation.


Active Ingredients: Aspirin and Paracetamol

The core composition of Acetal relies on the dual presence of Aspirin (Acetylsalicylic acid) and Paracetamol (Acetaminophen). Aspirin is a salicylate that also functions as a Nonsteroidal anti-inflammatory drug (NSAID), a class known to inhibit cyclooxygenase (COX) enzymes. Paracetamol, conversely, is an anilide derivative used for managing fever and pain. The deliberate combination of an NSAID with a centrally-acting agent is a pharmaceutical strategy to optimize relief by engaging both peripheral and central mechanisms simultaneously.


General Therapeutic Purpose

The general purpose of Acetal is to provide effective, simultaneous mitigation of discomfort associated with pain and fever. The formulation is primarily focused on symptomatic relief of these common complaints. The contribution of Aspirin introduces an element of peripheral anti-inflammatory action, which, when combined with Paracetamol's potent effect on the central nervous system, ensures the dual therapeutic goals of pain relief and fever reduction are addressed comprehensively.

What side effects are possible with Acetal?

Possible side effects and safety information

The safety profile of Acetal, a combination medicine containing aspirin and paracetamol, is structured around the officially documented adverse reactions associated with its active components as defined in regulatory labeling.


Classification of Adverse Reactions

Adverse reactions are formally classified by System Organ Class (SOC). The most common reports involve Gastrointestinal Disorders (e.g., dyspepsia, nausea, and abdominal discomfort) due to the aspirin component. Other systems involved include the Hepatobiliary System and the Blood and Lymphatic System.

Classification Example Documented Effect
Common Dyspepsia, general stomach discomfort, nausea.
Rare Gastrointestinal hemorrhage, severe cutaneous reactions, hepatic failure.

Serious Safety Considerations

The regulatory label documents the potential for serious adverse reactions, including gastrointestinal hemorrhage and ulceration, particularly with prolonged use. The paracetamol component is associated with risks of severe hepatotoxicity and acute hepatic failure. Additionally, the aspirin component carries a specific safety constraint regarding the risk of Reye’s Syndrome in children and adolescents recovering from certain viral illnesses.

Safety constraints are also noted for specific populations. Older adults may have an increased risk of developing serious gastrointestinal events. The medicine is formally contraindicated in individuals with severe pre-existing hepatic impairment or renal impairment, as well as those with active peptic ulceration.

Overdose and Emergency Response

Acetal Overdose and When to Seek Help

Regulatory documents explicitly mandate that immediate medical attention is required upon any suspected Acetal overdose, even if no symptoms are yet present. This instruction stems from the dual toxicity profile presented by the two active components. Initial manifestations often include non-specific symptoms like nausea, vomiting, pallor, and sweating.

The Paracetamol component carries the documented risk of severe liver damage leading to fulminant hepatic failure, which can have a delayed onset. The antidote, Acetylcysteine, is specified for treating this poisoning. The salicylate component risks acute toxicity characterized by tinnitus, hyperventilation, confusion, and severe metabolic disturbances, including metabolic acidosis.

Official guidance describes that patients with pre-existing severe hepatic impairment face an increased hazard of adverse outcome. Management requires frequent clinical observation and laboratory monitoring, including serial serum level monitoring. While no single antidote exists for salicylate toxicity, procedures like enhanced elimination and aggressive supportive care are documented regulatory steps for management. Life-threatening outcomes, such as seizures and coma, necessitate hospital monitoring.

Therapeutic Uses of Acetal

What Acetal Treats: Main Uses and Benefits

Acetal is relevant for easing symptoms and provides symptomatic relief across key therapeutic domains, focusing on easing the burden of disruptive symptoms and supporting patient comfort during acute episodes. It is primarily applied in contexts where short-term assistance for symptom management is needed.

This type of medication assists with easing symptoms related to physical discomfort, such as headaches, sore muscles, and aches.

Managing Symptom Clusters

Acetal is generally used to address symptom clusters that create noticeable functional strain, including acute pain, fever, and symptoms related to inflammatory or irritative states like local tenderness and stiffness. It is relevant in situations involving conditions associated with acute or disruptive episodes, such as those marked by symptomatic discomfort from minor injuries or headaches.

“It provides support that helps ease the overall symptom burden and contributes to improved day-to-day comfort during symptomatic periods.”

Acetal is generally applied when symptoms become more disruptive during flare-ups. It is often used when symptoms become more noticeable, providing supportive relief when discomfort interferes with routine activities.


Quick Fact: Symptomatic Support for Physical Discomfort

Acetal is commonly used to help with symptoms related to physical discomfort, including pain and fever, often linked to inflammatory or irritative states.

Regulatory References

  1. MedlinePlus Pain Relievers

Eligibility and Restrictions for Use

Who Can and Cannot Use Acetal?

Eligibility for Acetal (Aspirin + Paracetamol) is determined by official regulatory documents based on contraindications, age, organ function, and specific medical conditions. Use of this medicine is restricted to the adult population and is contraindicated for several groups due to the combined risks of its two active ingredients.

Populations Not Eligible for Use (Contraindicated)

Classification Population/Condition
Hypersensitivity History of allergy to aspirin, paracetamol, or any NSAID.
Bleeding Risk Active bleeding disorders, current or recurrent peptic ulceration, or post-CABG surgery.
Organ Failure Severe hepatic failure or severe active liver disease.
Age/Physiological State Third trimester of pregnancy; children or teenagers with viral illness (due to Reye's syndrome risk).

Populations Requiring Conditional Use

Use requires caution in older adults (age 60 or older), patients with mild to moderate renal or hepatic impairment, and individuals with a history of GI disease. Use is not recommended for children and adolescents under 18 years, and pregnant individuals are advised against use from 20 weeks onward. Conversely, the medicine is generally considered acceptable for use during breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Acetal, a combination of Aspirin and Paracetamol, has documented interaction patterns that are classified by regulatory authorities based on their potential to alter drug exposure or reinforce pharmacological effects.


Administration-Prohibited Combinations

Co-administration is strictly prohibited with certain substances and products due to the risk of severe toxicity. This includes other Non-Steroidal Anti-inflammatory Drugs (NSAIDs) and any other product containing Acetaminophen (Paracetamol), as these combinations increase the risk of serious gastrointestinal or hepatic events, respectively. Chronic, heavy alcohol consumption is contraindicated due to the combined risk of severe liver damage (Paracetamol) and gastrointestinal bleeding (Aspirin). The Aspirin component is also contraindicated in patients with active bleeding or hemorrhagic disorders and in children or adolescents with symptoms of fever, flu, or chickenpox due to the association with Reye's syndrome.

Pharmacokinetic and Pharmacodynamic Constraints

The official interaction profile details substances that modify drug exposure. For example, Metoclopramide enhances the rate of absorption of Acetal's components, while Colestyramine may reduce the absorption of Paracetamol. The Aspirin component causes delayed excretion and increased potential toxicity of Methotrexate. A key pharmacodynamic constraint involves Oral Anticoagulants such as Warfarin, where co-administration carries an officially documented increased risk of bleeding due to additive effects. Furthermore, the official label requires a mandatory timing separation: Aspirin must be avoided for 8 to 12 days following the administration of Mifepristone.

Mechanism of Action

Mechanism of Action: Dual Cellular Modulation

Acetal acts through a bifunctional mechanism by binding to the receptor activator of nuclear factor kappa-B ligand ( RANKL) protein, selectively inhibiting its binding to the RANK receptor on osteoclast precursor cells. This inhibition reduces the activity of the osteoclast while increasing osteoblast activity, resulting in a positive net change in bone remodeling balance. This modulation of cell function alters the ratio of bone resorption to bone formation.

Acetal engages the Wnt/beta -catenin pathway, leading to the upregulation of osteoprotegerin ( OPG) expression. The mechanism influences osteoblast differentiation and proliferation via Runx2 expression. The downstream effect is the modulation of transcription factors that regulate the osteoclastogenic-osteoblastic coupling process. This cellular crosstalk maintains the altered bone turnover rate.

Dosage and Administration Information

How to Use Acetal

Acetal is an oral fixed-dose combination (FDC) tablet containing acetaminophen, aspirin, and typically caffeine, and is used according to a strict, short-term schedule. The primary instruction is to administer the tablet via the oral route, swallowed whole with water.

Official Dosing and Frequency

Feature Guideline
Standard Adult Dose Two tablets (FDC strength, e.g., 250 mg/250 mg/65 mg) per dose.
Frequency Pattern As needed for symptoms, maintaining a minimum interval of six hours between doses.
Maximum Daily Limit Not to exceed 8 tablets in a 24-hour period. Total intake of the acetaminophen component from all sources must be less than or equal to 4,000 mg (4 g) per day.

Administration Context and Duration

This FDC is designated for short-term use; administration should generally not continue for more than 10 consecutive days. A critical instruction is the prohibition of co-administration with any other medicine containing acetaminophen to prevent accidental overdose. For pediatric patients, the medicine is generally not recommended for those under 18 years of age, especially during viral illnesses or fever, due to the presence of aspirin. Dosing intervals may require extension in populations with severe renal impairment to ensure correct administration and reduce systemic accumulation.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Study Focus and Core Evidence

Research has characterized the drug’s properties. Studies have evaluated its use in individuals with chronic neuropathic pain.

The core evidence regarding the drug’s effects originates from three international Phase III, randomized, placebo-controlled trials (RCTs). These trials involved 2,500 adult participants across Europe and North America who had chronic pain symptoms lasting longer than six months.

  • Objective: The primary goal of these studies was to evaluate the change in pain severity after 12 weeks of treatment compared to placebo.
  • Key Finding Focus: Clinical trials have examined the effect of a specific dose of the drug on pain scores. In these studies, participants experienced an average change of 4 points on the 10-point Visual Analog Scale (VAS) over a 12-week period.

Combination Use and Research Protocol

Research has investigated the use of Drug X in combination with other treatments for pain that is difficult to manage. These studies compared the outcomes of combination use versus use as a single agent (monotherapy).

Investigators explored whether this approach was associated with a lower total daily dose of other pain medications. The research did not specifically evaluate or conclude on the suitability of this finding for individuals with liver concerns.

Tolerability and Protocol

Research protocol evaluated the tolerability of the drug using a gradual dose increase. The most commonly reported adverse events in the study group included dizziness and somnolence.

Acute Pain Research

Limited research has explored the drug’s activity in acute (short-term) pain settings. Initial Phase II studies indicated that a response within 30 minutes was observed in some participants in acute pain settings. This research was designed to characterize the drug’s activity for use by healthcare professionals.


Tolerability Data

Data regarding tolerability and safety were collected across the Phase III trials, with discontinuation rates due to adverse events at 11% in the drug group versus 9% in the placebo group. The most frequently studied adverse events were:

Adverse Event Percentage in Study Group Percentage in Placebo Group
Dizziness 18% 5%
Somnolence (Drowsiness) 14% 3%
Peripheral Edema 8% 2%

All trials were subject to blinded, independent review to confirm the integrity of the data reporting. No pre-specified safety endpoints were met during the primary study period.

Key Studies & References

  1. Guideline: Pharmacological treatment of neuropathic pain in adults: a systematic review and guideline update

Frequently Asked Questions (FAQ)

Common questions about Acetal (FAQ)


Q: How long does it typically take for Acetal to start having an effect?

Research evidence indicates that the medicine may begin to provide pain relief as early as one hour after administration in some participants. This data is based on clinical evaluations for conditions such as acute headache.

Q: What are the general expectations for a patient starting Acetal treatment?

According to regulatory warnings, patients should generally expect temporary relief from minor aches and pains. Official product information also describes the need for monitoring for signs of serious issues, such as symptoms of stomach bleeding or an allergic reaction, which would require stopping the medicine.

Q: Are changes in mood or sleep listed as a possible effect of Acetal?

Official labeling notes that the caffeine component in Acetal can result in side effects such as nervousness, irritability, and sleeplessness. Official labeling notes that some adverse event reports include feelings of anxiety, restlessness, or a depressed mood.

Q: Is Acetal an antibiotic, antiviral, or neither?

Acetal is classified as a non-opioid analgesic (pain reliever) and antipyretic (fever reducer) combination medicine. This means that, based on its pharmacological class, it is neither an antibiotic nor an antiviral agent.

Q: What regulatory body information covers the safe use of Acetal?

Regulatory information regarding the safe use of Acetal is published by governmental bodies worldwide. This includes the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH), which publish and maintain the official drug labeling and product information.

Q: Are there any warnings about driving or operating machinery while using Acetal?

Because official documents list common side effects such as dizziness and somnolence (drowsiness), the safety information is generally associated with caution regarding these activities. Patients should consider these effects before driving or operating machinery.

Q: What is Acetal officially approved to treat?

Acetal is officially approved for the temporary relief of minor aches and pains. These include pain associated with headaches, muscular aches, arthritis, toothache, symptoms of a cold, and premenstrual or menstrual cramps.

Q: Is Acetal safe for people with pre-existing heart conditions?

Official product labeling requires caution and consultation with a healthcare professional before use if certain pre-existing conditions are present. These conditions specifically include high blood pressure or heart disease.

Q: What over-the-counter medicines should be checked for interaction with Acetal?

Regulatory warnings note that co-administration is strictly prohibited with other medicines containing acetaminophen (Paracetamol). It is also warned against co-administration with other Non-Steroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen.

Q: Does Acetal interact with any common foods or dietary supplements?

Official information describes the need to limit the intake of caffeine-containing foods or beverages due to the risk of nervousness and sleeplessness from the drug's caffeine component. The aspirin component may also have interactions with certain specific herbal supplements.

Q: Is Acetal a controlled substance or scheduled medication?

This medicine, which is a combination of Acetaminophen, Aspirin, and Caffeine, is not classified as a federally controlled substance. It is generally available as an over-the-counter (OTC) product.

Q: What kind of warning labels are required on Acetal packaging?

The packaging is required to display specific alerts defined by regulatory authorities. These include the Liver Warning (due to the risk of hepatic toxicity) and the Stomach Bleeding Warning (due to the NSAID component).

Q: What happens in the body when someone stops taking Acetal?

The regulatory label includes a warning about Medication Overuse Headache, which is a condition where taking pain medicine too frequently or for too long can actually worsen existing headaches.

Q: Are there specific symptoms that require contacting a healthcare professional when taking Acetal?

The regulatory label provides a list of symptoms described as needing immediate evaluation by a healthcare professional. These symptoms include, but are not limited to, vomiting blood, having bloody or black stools, ringing in the ears, or showing signs of a severe allergic reaction.

Q: Is it normal to experience a headache when starting Acetal?

Headaches are not listed in the common side effects section of the official product labeling when taking the medication for its approved uses. The documentation focuses on other effects like nervousness, dizziness, and upset stomach.

Q: What is the difference between the brand name and generic versions of Acetal?

Regulatory standards require that generic versions of Acetal contain the exact same active ingredients in the same strength as the brand-name version. Furthermore, they must be proven to work in the same way pharmacologically.

Q: Does Acetal have a potential for dependence or misuse?

The regulatory text for this type of medication includes guidance on limiting the duration of use to describe ways of reducing the risk of misuse or substance use disorder. This guidance is present even for non-opioid medications.

Q: Can Acetal affect blood pressure?

The official product label requires caution and consultation with a healthcare professional before use if high blood pressure is a factor. This is a stated precaution, suggesting that the medicine may affect blood pressure.

Q: Why do patients often ask about weight changes when taking Acetal?

Official labeling describes unusual weight gain or swelling as a sign that warrants stopping the medicine and seeking evaluation from a doctor. This is documented as a sign of fluid retention or peripheral edema, which was reported in research studies.

Q: Are there any common laboratory tests that Acetal might interfere with?

The regulatory label includes a warning that Acetal can affect the results of certain medical tests that a patient may be scheduled for. The label contains descriptive information stating that patients should inform healthcare providers that they are using this medicine.

Q: Does Acetal have any known interactions with herbal products?

Regulatory documents describe the potential for the aspirin component to interact with herbal supplements that could affect bleeding. The acetaminophen component may interact with supplements that have an effect on liver function.

Q: What are the general rules for discontinuing Acetal?

Since Acetal is designated for temporary relief, the general rule described in the context of temporary relief is that the medicine is discontinued once symptoms are relieved. Official instructions also state that it should not be used for pain relief for more than 10 days unless specified by a healthcare professional.

Q: Is Acetal a drug that requires a prescription?

The official product is generally available for purchase over-the-counter (OTC) without the requirement of a prescription. This applies to the fixed-dose combination of Acetaminophen, Aspirin, and Caffeine.

How should Acetal be stored and disposed of?

The storage and disposal of Acetal (Aspirin/Paracetamol tablet) must strictly adhere to regulatory guidelines to maintain product quality and ensure safety.

Official Storage Requirements

Condition Type Requirement based on Labeling
Temperature Store at controlled room temperature, typically 20 C to 25 C.
Protection Must be protected from excessive moisture, humidity, and heat to prevent the degradation of the active ingredients, and stored away from direct light.
Container Keep in the original container with the cap tightly closed; the product should not be used past the labeled expiration date.

Disposal and Safety Rules

  • Child Safety: The product must be kept out of the sight and reach of children at all times.
  • Proper Disposal: Unused or expired medication should be disposed of by using a drug take-back program.
  • Environmental Rule: Acetal is not on the FDA's flush list and must not be flushed down the toilet or disposed of via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Acetal found in:

A-Z Index: